Adverum Biotechnologies Inc (ADVM)
US$ 4.58-0.87%
Price Chart
Key Statistics
Market Cap
$ 46.38M
P/E Ratio
0.00
Revenue (TTM)
$ 1M
Volume
77.81K
52W High
$ 10.14
52W Low
$ 1.78
Dividend Yield
0.00%
Beta
1.02
Technicals
50-Day MA
3.2746
200-Day MA
5.3133
52 Week High
10.14
52 Week Low
1.78
About ADVM
Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases.
Employees
155
Headquarters
Redwood City, CA
CEO
Dr. Laurent Fischer
Latest News
ADVM stock touches 52-week low at $2.71 amid steep annual decline - Investing.com
2025-04-28 • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg